We are excited to announce that PEI has joined the list of provinces to have taken action and made Opsumit available through public funding!
top of page
Recent Posts
A new investigation, "A Canadian Initiative: Exploring Adult Pulmonary Hypertension," highlights critical issues such as diagnostic delays and accessibility challenges faced by PH patients. This compr
We are pleased to announce that sotatercept, a new drug for patients diagnosed with pulmonary arterial hypertension (PAH), is now listed on Health Canada's website with the mention “Being reviewed und
bottom of page